{"classes":[{"categories":[{"measurements":[{"comment":"Upper limit of the confidence interval was not reached.","groupId":"OG000","lowerLimit":"379","upperLimit":"NA","value":"751"}]}],"title":"Median PFS using the Kaplan-Meier Method"},{"categories":[{"measurements":[{"comment":"Upper limit of the confidence interval was not reached.","groupId":"OG000","lowerLimit":"829","upperLimit":"NA","value":"829"}]}],"title":"Median OS using the Kaplan-Meier Method"},{"categories":[{"measurements":[{"comment":"Upper limit of the confidence interval was not reached.","groupId":"OG000","lowerLimit":"414","upperLimit":"NA","value":"805"}]}],"title":"Median Time to Subsequent Therapy using Kaplan-Meier Method"}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"}],"units":"Participants"}],"description":"Progression-free survival (PFS) was calculated as the date from first immunization to first observation of disease progression or death due to any cause, censored on the start date of subsequent therapy or at the last date of disease assessment for subjects without a PFS event. Overall survival (OS) was calculated as the date from first immunization to death due to any cause, censored at the date of last follow-up for subjects who were alive at the time of the analysis. Time to subsequent therapy was calculated as the date from first immunization to start of subsequent therapy for myeloma, censored at the date of death or last follow-up for subjects who did not receive subsequent therapy.","dispersionType":"95% Confidence Interval","groups":[{"description":"Includes all subjects who received at least 1 immunization with study drug and had a baseline and at least 1 post-baseline disease assessment.","id":"OG000","title":"Evaluable Analysis Set"}],"paramType":"MEDIAN","populationDescription":"The Evaluable Analysis Set comprises all subjects who received at least 1 immunization with study drug and had a baseline and at least 1 post-baseline disease assessment.","reportingStatus":"POSTED","timeFrame":"Continuously on study and for up to 5 years post-study","title":"Assessment of Survival and Time to Subsequent Therapy","type":"SECONDARY","unitOfMeasure":"days"}